Here's what to expect this week on Diagnostic Imaging.
In this week’s preview, here are some highlights of what you can expect to see coming soon:
Not only does the United States spend the largest percent of its Gross Domestic Product on healthcare compared to other countries, but radiologists are also paid more here, by comparison, to anywhere else in the world. Research released this week from the United Kingdom takes a look at how countries value healthcare and where radiologists fall in compensation compared with other healthcare professionals. Look for the story later this week.
For more radiology compensation coverage, click here.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
Point-of-care ultrasound continues to grow in popularity, meaning that providers other than radiologists are becoming familiar with – and comfortable using – the modality. This week, Diagnostic Imaging speaks with two emergency providers about what non-radiologists need to know about the use of bedside renal ultrasound. Take a look at the story later this week to help better inform your non-imaging colleagues about how they can best use this tool.
For more coverage of renal imaging, click here.
Tomosynthesis has proven its value in better breast cancer detection. But, how is it being used across healthcare settings that may not have equivalent resources and expertise? This week, Diagnostic Imaging talks with Amy Patel, M.D., medical director of the Women’s Imaging Center at Liberty Hospital, about the impact tomosynthesis makes when used in conjunction with digital mammography in both academic and community settings. Keep your eyes open for the interview later this week.
For additional coverage on tomosynthesis, click here.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
FDA Clears Point-Of-Care Ultrasound Platform and AI Software for Neuraxial Procedures
July 17th 2025The dual FDA clearances for the Accuro 3S point-of-care ultrasound device and the SpineNav-AI machine learning-based software may enhance precision and safety with ultrasound-guided neuraxial procedures.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.
Mammography Study: AI Facilitates Greater Accuracy and Longer Fixation Time on Suspicious Areas
July 8th 2025While noting no differences in sensitivity, specificity or reading time with adjunctive AI for mammography screening, the authors of a new study noted a 4 percent higher AUC and increased fixation time on lesion regions.